Hedge Fund - Factorial Partners
Teva Pharmaceutical Industries Ltd (TEVA)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2025 - Q1 (2025-03-31) | $5,118,210 | 3.16% | 333,000 | $17.86 |
2 | 2024 - Q4 (2024-12-31) | $7,317,280 | 4.2% | 332,000 | $18.19 |
3 | 2024 - Q3 (2024-09-30) | $5,604,220 | 3.22% | 311,000 | $17.50 |
4 | 2024 - Q2 (2024-06-30) | $4,420,000 | 2.72% | 272,000 | $15.40 |
5 | 2024 - Q1 (2024-03-31) | $3,837,920 | 2.18% | 272,000 | $12.61 |
6 | 2023 - Q4 (2023-12-31) | $2,536,920 | 1.6% | 243,000 | $9.34 |
7 | 2023 - Q3 (2023-09-30) | $2,346,000 | 1.71% | 230,000 | $9.31 |
8 | 2023 - Q2 (2023-06-30) | $1,524,825 | 1.05% | 202,500 | $8.11 |
9 | 2023 - Q1 (2023-03-31) | $1,367,325 | 1.02% | 154,500 | $9.89 |
10 | 2022 - Q4 (2022-12-31) | $1,609,680 | 1.23% | 176,500 | $8.73 |
11 | 2022 - Q3 (2022-09-30) | $1,396,000 | 1.21% | 173,000 | $8.84 |
12 | 2022 - Q2 (2022-06-30) | $1,087,000 | 0.88% | 144,500 | $8.71 |
13 | 2022 - Q1 (2022-03-31) | $1,418,000 | 0.97% | 151,000 | $8.35 |
14 | 2021 - Q4 (2021-12-31) | $705,000 | 0.46% | 88,000 | $9.03 |
15 | 2021 - Q3 (2021-09-30) | $1,510,000 | 1.02% | 155,000 | $9.36 |
16 | 2021 - Q2 (2021-06-30) | $1,535,000 | 1.03% | 155,000 | $10.58 |
17 | 2021 - Q1 (2021-03-31) | $1,788,700,000 | 1.25% | 155,000 | $11.47 |
18 | 2020 - Q4 (2020-12-31) | $1,495,750,000 | 1.25% | 155,000 | $9.58 |
19 | 2020 - Q3 (2020-09-30) | $1,396,550,000 | 1.42% | 155,000 | $10.58 |
20 | 2020 - Q2 (2020-06-30) | $1,886,000 | 2.06% | 153,000 | $11.31 |
21 | 2020 - Q1 (2020-03-31) | $1,373,000 | 1.83% | 153,000 | $10.25 |
22 | 2019 - Q4 (2019-12-31) | $1,528,000 | 1.22% | 156,000 | $8.93 |
23 | 2019 - Q3 (2019-09-30) | $1,073,280,000 | 1.03% | 156,000 | $7.66 |
24 | 2019 - Q2 (2019-06-30) | $1,439,880,000 | 1.38% | 156,000 | $12.06 |
25 | 2019 - Q1 (2019-03-31) | $2,430,400,000 | 2.28% | 155,000 | $17.63 |
26 | 2018 - Q4 (2018-12-31) | $2,297,580,000 | 2.4% | 149,000 | $20.50 |
27 | 2018 - Q3 (2018-09-30) | $3,209,460,000 | 2.75% | 149,000 | $23.22 |
28 | 2018 - Q2 (2018-06-30) | $3,720,960,000 | 3.32% | 153,000 | $20.39 |
29 | 2018 - Q1 (2018-03-31) | $2,614,770,000 | 2.38% | 153,000 | $19.52 |
30 | 2017 - Q4 (2017-12-31) | $2,785,650,000 | 2.57% | 147,000 | $15.04 |
The displayed share prices are average quarterly stock market prices.